FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 358:213-216 January 17, 2008 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Audio Interview Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Recent media reports have highlighted the increasing incidence of breast cancer in low- and middle-income countries. Although the disease continues to be most prominent in affluent countries, the risks of both breast cancer and death due to breast cancer are clearly increasing worldwide (see maps). Some 45% of the more than 1 million new cases of breast cancer diagnosed each year, and more than 55% of breast-cancer–related deaths, occur in low- and middle-income countries.¹ Such countries now face the challenge of effectively detecting and treating a disease that previously was considered too uncommon to merit the allocation of precious . . . [Full Text of this Article]

Source Information

Dr. Porter is a cancer biology researcher at the Fred Hutchinson Cancer Research Center and a professor of pathology at the University of Washington School of Medicine — both in Seattle.

An interview with Dr. Porter can be heard at www.nejm.org.

This article has been cited by other articles:

• Ali, R., Raina, V. (2008). Developing innovative models for North-South cooperation in clinical research--experience from the INDOX Cancer Research Network. Ann Oncol 19: 831-833 [Full Text]